Predicting diabetes risk after partial pancreas removal
Part of Digestive system, Hormones & metabolism clinical trials.
This trial studies how to predict if someone will develop diabetes after having part of their pancreas removed. It may help people who are scheduled for this surgery understand their risk and get earlier care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are scheduled to have part of your pancreas removed
- You do not currently have diabetes
- You have not had borderline high blood sugar or impaired glucose tolerance
- You are willing and able to give written consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows patients who are having part or all of their pancreas removed due to disease. Researchers want to understand how this surgery affects blood sugar control, weight, and overall health in people without diabetes before surgery.
This study follows patients with diabetes who are having surgery to remove part or all of their pancreas (usually for cancer or benign disease). Researchers will track how the surgery affects blood sugar control, weight, and overall health over time.
This trial studies pancreatic islets (cells that make insulin) from people who are having part or all of their pancreas removed. It may help researchers learn more about how the pancreas works in health and disease.
This trial studies how pancreatic cancer affects blood sugar and the risk of developing diabetes after surgery. Patients who have their pancreas removed will provide blood and tissue samples to help understand this link.
This study explores how the pancreas and diabetes are connected by examining people with different pancreatic conditions. It aims to find new ways to treat or prevent diabetes.
This study tests a hybrid closed-loop insulin delivery system (MiniMed 780G with Simplera sensor) in people who have had their pancreas removed. The system automatically adjusts insulin based on glucose levels, which may make diabetes management easier and safer.
Hear when a new Pancreatogenic Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.